NAV

Ribose

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Ribose
DrugBank Accession Number
DB15073
Background

Ribose is under investigation in clinical trial NCT01727479 (Ribose and Sport Performance).

Type
Small Molecule
Groups
Investigational
Structure
3D
Similar Structures
Weight
Average: 150.1299
Monoisotopic: 150.05282343
Chemical Formula
C5H10O5
Synonyms
  • aldehydo-D-ribose
  • D-ribo-2,3,4,5-tetrahydroxyvaleraldehyde
  • D-Ribose
  • Ribose
Poor quality drug data slowing you down?
Unlock 38% more drug discovery time and eliminate decision-making doubts with this one-stop guide to quality drug data.
Download eBook
Poor quality drug data slowing you down?
Download eBook

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
681HV46001
CAS number
50-69-1
InChI Key
PYMYPHUHKUWMLA-LMVFSUKVSA-N
InChI
InChI=1S/C5H10O5/c6-1-3(8)5(10)4(9)2-7/h1,3-5,7-10H,2H2/t3-,4+,5-/m0/s1
IUPAC Name
(2R,3R,4R)-2,3,4,5-tetrahydroxypentanal
SMILES
[H]C(=O)[C@H](O)[C@H](O)[C@H](O)CO

References

General References
Not Available
ChemSpider
4470639
RxNav
1314858
ChEBI
47014
ZINC
ZINC000018168713
PDBe Ligand
RB5
Wikipedia
Ribose
PDB Entries
3ph3 / 6nch / 6nci

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
2CompletedTreatment5'-Nucleotidase Syndrome1
2CompletedTreatmentFibromyalgia1
2CompletedTreatmentHeart Failure, Diastolic1
2Not Yet RecruitingTreatmentFallopian Tube Cancer / High Grade Endometrioid Ovarian Cancer / High Grade Serous Adenocarcinoma of Ovary / Ovarian Cancer / Primary Peritoneal Cancer1
2RecruitingTreatmentClear Cell Renal Cell Carcinoma / Endometrial Cancer / Locally Advanced Malignant Solid Neoplasm / Locally Advanced Pancreatic Cancer (LAPC) / Metastatic Castration-Resistant Prostate Cancer (mCRPC) / Metastatic Malignant Solid Neoplasms / Metastatic Renal Cell Carcinoma ( mRCC) / Metastatic Urothelial Carcinoma (UC) / Pancreatic Carcinoma Stage III / Pancreatic Metastatic Cancer / Stage III Renal Cell Carcinoma / Stage IV Pancreatic Cancer / Stage IV Renal Cell Cancer1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility380.0 mg/mLALOGPS
logP-2.3ALOGPS
logP-2.9Chemaxon
logS0.4ALOGPS
pKa (Strongest Acidic)12.34Chemaxon
pKa (Strongest Basic)-3Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count5Chemaxon
Hydrogen Donor Count4Chemaxon
Polar Surface Area97.99 Å2Chemaxon
Rotatable Bond Count4Chemaxon
Refractivity31.38 m3·mol-1Chemaxon
Polarizability13.39 Å3Chemaxon
Number of Rings0Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
GC-MS Spectrum - GC-MS (1 MEOX; 4 TMS)GC-MSsplash10-0udi-1920000000-2a376699e06455c76ff7
GC-MS Spectrum - GC-MS (1 MEOX; 4 TMS)GC-MSsplash10-0uxr-0941000000-7b9d79f55ddb22a39810
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-014i-4900000000-87a5802bd0eea2d5b2b3
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-0ab9-9100000000-f9a2e0aedcc699306304
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-03k9-9100000000-afa0fa78c85a9bf063e2
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0ab9-9000000000-151fa4479f931410b10c
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0006-9000000000-ab1ea87836e9c68eaabf
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0a4l-9000000000-affbe16be52c4ef3b9c8
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-128.9347907
predicted
DarkChem Lite v0.1.0
[M-H]-129.0263907
predicted
DarkChem Lite v0.1.0
[M-H]-130.02922
predicted
DeepCCS 1.0 (2019)
[M+H]+130.2741907
predicted
DarkChem Lite v0.1.0
[M+H]+131.1734907
predicted
DarkChem Lite v0.1.0
[M+H]+132.40216
predicted
DeepCCS 1.0 (2019)
[M+Na]+128.9681907
predicted
DarkChem Lite v0.1.0
[M+Na]+129.0103907
predicted
DarkChem Lite v0.1.0
[M+Na]+138.75218
predicted
DeepCCS 1.0 (2019)

Drug created at May 20, 2019 14:47 / Updated at June 12, 2020 16:53